At Cogniverse 2026, Ivory Brings Clinical Experts Together to Advance Brain Health and Early Detection in India

▴ Rahul Krishnan (co-founder & CPO, Ivory), Dr Sid Warrier, Dr Sumiti Sahran, Dr Anoop Amarnath, Dr Ratnavalli Ellajosyula, Dr Sanjay Arora, Issac M. John (co-founder & CEO, Ivory)
Key discussions explored how lifestyle risks like isolation, hypertension, and diabetes impact cognitive decline, alongside the rise of “entertainment deafness” from prolonged earbud use.

Mumbai, India, March 23, 2026: Ivory, a neuroscience-backed brain health platform, recently hosted Cogniverse 2026, a first-of-its-kind forum focused on preventive brain health and early detection in India. Held in Mumbai, the event brought together over 150 Clinicians and healthcare Leaders, including neurologists, psychiatrists, psychologists, neuropsychologists, and geriatricians, to discuss the growing need to address cognitive decline earlier and more proactively.

Designed as a clinician-first platform, Cogniverse aimed to bring together different medical perspectives and encourage a more practical, early approach to brain health, moving beyond treatment at later stages.

Built around the idea of shifting from reactive care to preventive brain health, the forum explored how regular screening, everyday lifestyle changes, and more structured clinical approaches can play a role in maintaining cognitive health over time.

The event featured a series of expert-led sessions and panel discussions. Key discussions included the impact of lifestyle risk factors - such as social isolation, high blood pressure, and diabetes - on cognitive decline, and the rising phenomenon of "entertainment deafness" caused by prolonged earbud use. Across conversations, experts highlighted the importance of making brain health easier to understand, track, and act on.

The keynote address was delivered by Dr Ratnavalli Ellajosyula, MD, DM, FAAN, Senior Consultant Neurologist and specialist in Cognitive Neurology, on “New Era of Dementia: Global Science, Local Reality”, where she highlighted the necessity of bridging the gap between global neurological advancements and specific diagnostic challenges faced in the Indian context. She emphasised that while dementia is a global crisis, local reality requires decentralised screening and early intervention models that are accessible to the aging population in India. Dr Ellajosyula is an internationally recognised expert in dementia and a pioneer in the field, having started one of India’s first memory clinics in 1998. She heads the multidisciplinary cognitive neurology clinic (CNC) at Manipal Hospitals and Annasawmy Mudaliar Hospital, Bangalore and Neurocare clinic, Mysuru.

The forum also saw participation from Dr Sanjay Arora, Dr Anoop Amarnath, Dr Sid Warrier, Dr Prakhar Jain, Jwala Narayanan, and Dr Sumiti Saharan, among others.

Cogniverse 2026 spotlighted the "Brain as the Master Clock of Longevity," demonstrating how AI-driven early detection combined with neuroplasticity can extend the human healthspan. The forum was hosted in collaboration with Dementia India Alliance, Metropolis, Agappe Diagnostics, The Wisdom Club, and The Warrier Clinic.

Dr Sumiti Saharan, Chief Scientific Officer, Ivory, said, “India is at a critical point when it comes to brain health. A large part of cognitive decline goes unnoticed until it begins to impact daily life, which limits the effectiveness of interventions. What we need is a stronger focus on early risk identification, along with clearer, standardised approaches that clinicians can adopt in everyday practice. Preventive brain health requires consistent, science-backed frameworks that can be scaled across the healthcare system. Therefore, Cogniverse plays a crucial role in bringing clinicians together to build more structured, science-backed approaches that can be applied in everyday healthcare.

Issac M. John, Co-Founder & CEO, Ivory, added, “This day was two and a half years in the making for us. India is ready for this conversation because of strong tailwinds in the detection of Alzheimer’s disease-modifying therapies, and clear evidence that multi-modal lifestyle interventions have a tremendous impact on our healthspan. Our partnerships with several scaled players in the healthcare ecosystem also show that India is now ready to move from advocacy to active application.”
 

With a packed room, the event saw participation from healthcare professionals from a wide range of specialisations, including diagnostic chains, preventive health clinics, mental health collectives and community healthcare professionals. 

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026